News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Neanderthals Are People, Too

By Svante Paabo, The New York Times | 04.24.2014
LEIPZIG, Germany — I NEVER met my paternal grandfather. He died of the Spanish flu in 1919 at the age...
Bioethics

Guidelines for Finding Genetic Variants Underlying Human Disease

By Daniel MacArthur and Chris Gunter, Genomes Unzipped | 04.24.2014

New DNA sequencing technologies are rapidly transforming the diagnosis of rare genetic diseases, but they also carry a risk: by...

Biotech & Pharma

Bracing For A Battle, Vermont Passes GMO Labeling Bill

By Eliza Barclay and Jeremy Bernfeld, NPR | 04.24.2014
The Green Mountain State is poised to become the first to require food companies to label products containing genetically modified...
Biopolitics

Invoking ‘Choice’ When Discussing Surrogacy as a Feminist Concern is a Mistake

By Susan Berke Fogel, Francine Coeytaux, Marcy Darnovsky, Lisa Ikemoto, and Judy Norsigian, RH Reality Check | 04.23.2014
It is troubling to see the vexing question of commercial surrogacy treated as a litmus test for feminists at RH...
Bioethics

NIPS SPIN

By Robert Resta, The DNA Exchange | 04.21.2014
Untitled Document

Advertising is the art of making whole lies out of half truths. ~Edgar A. Shoaff

Every few...

Genomics

Is Illumina’s $1,000 Genome a Reality? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert

By Joseph Burns, Dark Daily | 04.21.2014
Untitled Document

It was January when headlines nationwide trumpeted Illumina’s introduction of the $1,000 genome. The story in ...

Biotech & Pharma

Geneticist Cynthia Kenyon is Heading to Google

By Stephanie M. Lee, San Francisco Chronicle | 04.20.2014
Google's mysterious health venture dedicated to extending human life has quietly lured a prominent scientist away from UCSF, The Chronicle...
Biopolitics

Should the U.S. Prohibit Reproductive Cloning?

By Tim Sandle, Digital Journal | 04.18.2014
Untitled Document
Researchers have produced stem cell lines using somatic cell nuclear transfer (SCNT) from cells, making human reproductive cloning...
Human Cloning